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Abstract Reliable and efficient DNA and RNA transfection
methods are required when studying the role of individual
genes in mouse pluripotent stem cells. However, these cells
usually grow in tight clusters and are therefore more difficult
to transfect than many other cell lines. We have found that
transfection is especially challenging when mouse embryonic
stem (mES) cells are cultured in the newly described 2i medi-
um, which is based on two chemical inhibitors of differentia-
tion pathways. In the present study we have performed a side-
by-side comparison of commercially available, non-viral
transfection reagents with regard to their ability to deliver
plasmid DNA and siRNA into adherent and/or trypsinized
mES cells cultured in 2i medium, assessing transfection rates,
plasmid gene expression, siRNA mediated knockdown of
Oct4 and viability. Finally, we present a fast and efficient
method for transfection of trypsinized mES cells using the
liposomal-based Lipofectamine 2000. With only a five-
minute long transfection time we obtained at least 85 %
transfected cells with 80 % maintained viability. Moreover,
this protocol saves up to a day of experimental time since
the cells are in suspension at the time of transfection, which
allows for immediately re-plating into the appropriate format.
This fast, simplified and highly efficient transfection method
will be valuable for both basic research and high-throughput
applications.
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Introduction
For the last decades mouse embryonic stem (mES) cells have
been considered to be one of the most interesting model sys-
tems for basic cellular and molecular studies and developmen-
tal research. The ability to efficiently transfer DNA or small
interfering RNA (siRNA) is one of the key technologies used
for studying the role of single genes in these cells. However,
mES cells grow in tight clusters and are therefore quite inef-
ficiently transfected using chemical reagents. In addition, we
have found that when mES cells are cultured in the serum-free
2i medium (containing two inhibitors, against the mitogen-
activated protein kinase (MAPK)/extracellular-signal-regulat-
ed kinase (ERK) kinase (MEK) and the glycogen synthase
kinase 3 (GSK3), respectively [1]), chemical transfection is
even more challenging as compared to when cells are cultured
in standard culture media [2]. Replacement of serum by
targeted inhibition of relevant signaling pathways reduces cel-
lular heterogeneity as well as transcriptome and epigenome
differences in mES cell cultures [3, 4]. In 2i medium
PD0325901 inhibits the autocrine activation of the ERK1/2
pathway by fibroblast growth factor-4 (FGF4), shown to be
instrumental for ES cell differentiation [5]. The GSK3 inhibi-
tion impairs Tcf3 activity, which represses the core
pluripotency network in mES cells [6]. The cell cultures ex-
hibit a more dense and uniform morphology, with negligible
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signs of spontaneous differentiation as compared to cells cul-
tured in serum-containing media [2].
There are many vastly different transfection techniques
available [7]. Virus-mediated transfections, or so-called bio-
logical transfection methods, are suitable for stable transfec-
tions due to the integration of transfected DNA into the host
cell genome. However, although viral methods are usually
highly efficient they suffer from limitations such as time-
consuming production of vectors, mutagenesis, cytotoxicity,
and DNA size restriction [8]. Physical transfection methods
are the means of diverse physical tools to deliver nucleic acids
into host cells. Despite being effective, these methods are both
complicated and time-consuming (e.g. micro injections) or
may cause massive cell death (e.g. electroporation and
nucleofection). En masse they also require expensive in-
house equipment. Instead, much effort has been put into the
development of chemical methods, such as calcium phos-
phates, cationic lipids, cationic polymers, dendrimers,
polyethylenimine, peptides and nanoparticle-based com-
pounds [7]. Although generally less efficient in delivering
DNA, these non-viral vectors have higher genetic material
carrying capacity, are easier to produce and cause low cyto-
toxicity. However, many challenges remain, such as increas-
ing transfection efficacy while maintaining or reducing cyto-
toxicity, as well as improving penetration of cells that are
difficult to transfect.
Here we present a side-by-side comparison of commercial-
ly available, non-viral transfection reagents for plasmid DNA
or siRNA delivery using the manufacturers’ instructions. For
DNA and RNA delivery we selected some of the most com-
monly used reagents on the market, both liposomal and non-
liposomal polymer based. In addition we have also used a
positively charged polymer embedded into a porous carrier
nanoparticle. One of the unique challenges when transfecting
mES cells is that these cells often grow in dense multilayered
colonies, leading to lower transfection rates in the cells that are
positioned in the middle of the colonies. Hence, in the present
study we have transfected both adherent colonies as well as
cells dispersed into single cell suspensions.We here present an
optimized, rapid, single-cell suspension transfection protocol,
which results in unparalleled efficacy while maintaining low
post-transfection toxicity.
Material and Methods
Embryonic Stem Cell Culturing
Feeder-independent E14 and R1mES cells were cultured in 2i
medium [1], a serum-free N2B27 medium supplemented with
MEK inhibitor PD0325901 (1 μM) and GSK3 inhibitor
CHIR99021 (3 μM) (both from Selleckchem), and 1000 U/
ml LIF (Millipore). TrypLE™ Express (Life Technologies)
was used to passage the cells. To ensure good adherence
2 % ES-qualified FBS was supplemented to the 2i media
when seeding the cells, as previously described [2].
Transfections
Transfections with Lipofectamine® 2000 (herein named
L2K), Lipofectamine® 3000 (L3K, Life Technologies),
TurboFect™ (GE Healthcare Dharmacon), FuGENE® HD,
ViaFect™ (Promega), TransIT-2020®, TransIT-X2®,
TransIT-TKO®, TransIT-siQUEST® (Mirus Bio), Xfect™
mESC (Clontech), X-tremeGENE™ HP, X-tremeGENE™ 9
(Roche), Nanofectin, Nanofectamin (PAA, now part of GE
Healthcare), JetPrime™ (Polyplus transfection) were performed
according to the manufacturer’s instructions within the recom-
mended reagent/DNA or reagent/siRNA ratio range. For adher-
ent plasmid-DNA transfections cells were plated at constant den-
sity 2 x 105 cells/well in 12 well-plates one day prior to transfec-
tion. For the single cell suspension; 5 x 105 cells/well were
transfected and plated in 12 well-plates. The pmaxGFP
(AMAXA Biosystems), pCMV β-galactosidase, or pCAGGs
heparanase vectors were introduced at a final concentration of
1.5 μg DNA/well. For the adherent siRNA transfections; cells
were plated at a density 5 x 104 cells/well in 24 well plates one
day prior to transfection with either scrambled siRNA or siRNA
against Oct4 at a final concentration of 50 or 100 nM/well. For
the siRNA single cell suspension transfections; cells were
transfected and plated at a density 5 x 104 cells/well in a 24 well
plates. (sense 5′-AGGUGUUCAGCCAGACCACTT-3′, anti-
sense 5′-GUGGUCUGGCUGAACACCUTT-3′).
Flow Cytometry
24 h post-transfection, cells were washed once with PBS and
then trypsinized using TrypLE™ Express for 5 min at 37 °C.
Cell suspensions were analysed in a Becton Dickinson
FACSCalibur flow cytometer for FL1 (GFP) fluorescence to
determine the percentage of reporter expressing cells.
Background fluorescence and autofluorescence were deter-
mined using non-transfected cells as control. Analysis was
carried out in the freeware Flowing Software (http://www.
flowingsoftware.com).
Western Blot
Cells were harvested in lysis buffer as previously described
[9]. Total protein concentration was measured using BCA
Protein Assay kit (Pierce). Samples were run on 10 % SDS
PAGE gels, and subsequently transferred to an Immobilon-FL
membrane (Millipore). The membranes were blotted with an-
ti-Oct3/4 (POUF5F1, cl. 7F9.2 (Millipore) and anti-β actin
ab8229 (Abcam). The membranes were then incubated with
Alexa Fluor anti-rabbit 680 and IRDye 800CW anti-mouse.
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Immunosignals were imaged using an Odyssey fluorescent
imaging scanner (LI-COR Biosciences).
Β-Galactosidase Activity Assay
Twenty-four hours post-transfection cells were harvested in
lysis buffer and mixed with ONPG buffer (60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgCl2,
50 mM 2-mercaptoethanol, 1.2 mM ONPG) in a microtiter
plate and incubated at 37 °C for 30 min. Absorbance was read
at 420 nm in a microplate photometer reader (withMultiscan®
PLUS, Labsystems).
qPCR
Twenty four and 48 h post-transfection total RNAwas extracted
and purified with the GenElute™ mammalian total RNA
miniprep kit (Sigma-Aldrich) according to the manufacturer’s
instructions. First-strand cDNA was produced according to the
manufacturer’s protocol with iScript™ cDNA synthesis kit (Bio-
Rad) using 1 μg RNA. Quantitative real-time PCR was per-
formed according to the manufacturer’s instructions using the
SsoFast™ EvaGreen™ supermix on the Miniopticon™ Real-
Time PCR Detection System (Bio-Rad). The average C(t) value
for each gene was normalized against 18S and the comparative
Ct value (fold change) was calculated using 2
−ΔΔC(t). Primers




Dab2 (forward: TGAAGCAGACAGCCAGAACA, re-
verse: CAACAGACAAGGATTTGATAGGG).
Results
Efficiency of siRNA Delivery
The liposomal-based Lipofectamine2000 (L2K) and
Lipofectamine 3000 (L3K), which allegedly works equally
well for both siRNA and plasmid DNA, and the polymer-
based TransIT-X2 TransIT-TKO, TransIT-siQUEST, X-
tremeGENE siRNA, Xfect mESC and Nanofectin siRNA
were evaluated. E14 mES cells were transfected, according
to the manufacturers’ instructions, with 100 nM of siRNA
against the pluripotency gene Oct3/4, or scrambled siRNA
as negative control and subsequently analyzed for Oct3/4 ex-
pression by qPCR after 24 and 48 h. All transfection reagents
significantly reduced Oct3/4 mRNA expression at both 24 and
48 h post-transfection, as compared to cells transfected with
100 nM scrambled siRNA (Fig. 1a). The most efficient Oct3/4
knockdown were achieved with TransIT-X2, TransIT-
siQUEST and X-tremeGENE siRNA, showing more than
80 % decrease of Oct3/4 mRNA levels after 48 h. L2K,
L3K and Nanofectin siRNAmediated 70% decrease, whereas
TransIT-TKO and Xfect mESC achieved around 50 % knock-
down. Although, TransIT-siQUEST mediated the greatest re-
duction in Oct4 mRNA levels, the reagent generated more
acute toxicity as compared to TransIT-X2 and X-
tremeGENE and was therefore omitted from further analysis.
Oct3/4 down-regulation is known to lead to differentiation
of mES cells [4]. Hence, to determine the efficacy of the
siRNA mediated Oct3/4 knockdown, expression of the early
endoderm differentiation gene Dab2 was assessed in the same
qPCR samples as used for assessing Oct3/4 levels 48 h post-
transfection (Fig. 1a). As expected, the samples with the best
Oct3/4 knockdown showed the highest increase in Dab2
mRNA levels 48 h post-transfection. Western blotting for
Oct3/4 protein expression after 72 h of transfection further
confirmed the high knockdown efficacy obtained with the
four most efficacious siRNA delivery reagents as assessed
by level of RNA interference and cell survival (Fig. 1b).
Trypan blue exclusion assay was then used to assess the tox-
icity of these four reagents 24 and 48 h post-transfection with
the scrambled siRNA. The results showed no significant dif-
ferences between the various reagents when using scrambled
siRNA independent of time-point although Nanofectin ap-
peared slightly more toxic to the cells (Fig. 1c). Cells
transfected with Oct4 siRNA showed reduced viability as
compared to cells transfected with scrambled siRNA and sur-
vival decreased over time suggesting that the Oct4 knock-
down in combination with transfection negatively affects cells
survival.
Efficiency of DNA-Plasmid Delivery in Adherent Cells
Three liposomal based reagents (L2K, L3K, and
Nanofectamin) as well as nine non-liposomal polymer based
reagents (TurboFect, FuGENE HD, TransIT-2020, TransIT-
X2, Xfect mESC, X-tremeGENE HP, X-tremeGENE 9,
ViaFect, JetPrime) were evaluated for DNA-plasmid transfec-
tion. In addition, we also included Nanofectin; a positively
charged polymer embedded into a porous carrier nanoparticle.
The mES cell line E14 was transfected with pmaxGFP, an
expression vector holding the gene for an advanced version
of enhanced green fluorescent protein (GFP) under the control
of the cytomegalovirus (CMV) promoter. In parallel experi-
ments the cells were mock transfected to serve as negative
controls. Twenty-four hours post-transfection cells were proc-
essed for flow cytometry analysis. The efficacy varied mark-
edly between reagents (Fig. 2a). The highest efficiency was
observed using the Xfect mESC transfection reagent,
exhibiting 55 % GFP-positive cells when used at a DNA/
reagent ratio of 2:1. The liposomal-based transfection reagents
L2K (DNA/reagent ratio 1:4) and Nanofectamin (1:6) both
exhibited efficiencies of 34 % and 29 %, respectively, while
586 Stem Cell Rev and Rep (2016) 12:584–591
the remaining reagents never achieved more than 25 % trans-
fection efficiencies. The five best-performing reagents were
examined under fluorescent microscopy (Fig. 2b) and a trypan
blue exclusion assay was performed 24 h post-transfection to
evaluate toxicity for these reagents. All tested reagents main-
tained an 85 % survival rate or higher with no significant
differences between groups (Fig. 2d).
Efficiency of DNA-Plasmid Delivery in Single Cell
Suspension
To assess whether 2i-cultured cells are more easily transfected
when dissociated into single cells, E14 mES cells were
trypsinized and then directly transfected using the same
DNA/reagent ratios as presented above. For all transfection
reagents 500.000 cells/sample were transfected with 1.5 μg
pmaxGFP for two hours and subsequently seeded onto plates
in 2i medium supplemented with 2% FBS. Twenty-four hours
post-transfection cells were processed for GFP expression
using FACS analysis. Although Xfect generated the highest
transfection efficiency (Fig. 2c), this reagent was found to be
highly toxic to cells in suspension and only a small fraction of
the cells survived and could re-attach to plates after transfec-
tion. This is also reflected by the lowest amount of β-gal
activity compared to the other tested reagents (Fig. 3). In ef-
fect, there were too few cells to even perform the trypan blue
exclusion assay. In contrast, the liposomal-based transfection
reagents, L2K (1:4) and Nanofectamin (1:6) generated accept-
able transfection rates of 63 % and 49 %, respectively with
good survival (Fig. 2c). Viability was assessed 24 h post-
transfection for the five most efficient reagents using trypan blue
exclusion assay. Lower viability was observedwhen transfecting
trypsinized cells as compared to adherent cultures and the toxic-
ity level coincided with the transfection rate (Fig. 2e).
The five most efficient reagents from the initial screenings
were then used for transfecting cells with a β-galactosidase
(β-gal) reporter construct. Theβ-gal activity results concurred
with the results presented above, both as to the efficiency of
the different reagents but also that transfection rate of single
cells exceeds that of adherent cultures (Fig. 3).
Fast and Efficient DNA-Plasmid and siRNA Delivery
in Suspended mES Cells
In an attempt to decrease toxicity and further optimize trans-
fection of trypsinized mES cells DNA/reagent ratios were al-
tered and shorter transfection times were tested. Since L2K
had generated the most promising results we chose this re-
agent for the initial experiments. A similar set-up, as presented
above, was used using the GFP reporter construct at DNA/
reagent ratios of 1:1, 1:2 and 1:4. The 1:2 and 1:4 DNA/
reagent ratios was found to be significantly more efficient than
the 1:1 ratio (supplemental Fig. 1a). However, since no differ-
ence between the 1:2 and 1:4 ratios could be discerned, we
continued with the 1:2 ratio to reduce toxicity. Transfection
times were then decreased from two hours to 60 and 30 min.
Our results showed that the transfection rates were similar
independent of incubation time (supplemental Fig. 1b). The
Fig. 1 a Quantitative PCR
analysis for Oct3/4 (24 and 48 h)
and Dab2 (48 h) after transfection
of E14 mES cells with either
100 nM siOct3/4 or scrambled
siRNA using L2K (2 μl), L3K
(1.5 μl), TransIT-X2® (3 μl),
TransIT-TKO® (3 μl), TransIT-
SiQuest® (5 μl), Xfect™ mESC
(8 μl), X-tremeGENE™ siRNA
(5 μl), and Nanofectin siRNA
(8 μl). 18S expression was used for
normalization, and results are
comparative Ct value means ± SD
(n = 3). bWestern blot analysis for
β-actin and Oct3/4 72 h post-
transfection with siOct3/4 or
scrambled siRNA using the four
best-performing reagents in 1 a. c
Trypan blue dye exclusion assay for
cell viability 24 and 48 h post-
transfection with siOct3/4 or
scrambled siRNA using the same
reagents as in 4b. Results are
mean ± SD (n = 3)
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transfection time was subsequently further shortened to 15, 10
and 5 min. For these experiments we also included
Nanofectamin (1:6). Again no significant differences in transfec-
tion efficiency were observed between the different incubation
times (Fig. 4a). Hence, only 5-min incubation in suspension was
needed to obtain about 90 % transfection efficacy with L2K and
about 60 % with Nanofectamin. Furthermore, the toxicity
seemed to decrease with shorter suspension times and was sig-
nificantly lower with the 5-min transfection time (Fig. 4b). To
corroborate our results we subsequently compared the 5-min
single cell suspension transfection to cells cultured adherently
in 2i media. Both L2K and Nanofectamin show significantly
higherβ-gal activity 24 h post-transfection after 5-min single cell
suspension transfection compared to standard adherent cell trans-
fection procedures in both E14 and R1 mES cells (Fig. 4c and
4d). In addition, E14mES cells were transfected with a construct
encoding the endoglycosidase heparanase. The apparent differ-
ence in expression levels of heparanase as shown by Western
blotting further substantiates the advantages of the single-cell
transfection procedure (Fig. 4e). Next, to see whether these short
transfection conditions are applicable to adherent conditions as
well, we shortened the transfection times for DNA-plasmid de-
livery in adherent cultures. However, our results showed that in
adherent cultures there is a clear correlation between incubation
time and transfection efficiency for both L2K and Nanofectamin
(Fig. 4f).
Finally, to validate if short-time single cell suspension
transfection works equally well for siRNA delivery, similar
set-up, as presented above, was tested using L2K and
Fig. 2 a Flow cytometry quantification of GFP-expressing E14 mES
cells 24 h post-transfection of adherent cultures using L2K (DNA/reagent
ratio 1:4), TurboFect™ (1:4), FuGENE®HD (1:4), TransIT-2020® (1:4),
Xfect™ mESC (2:1), X-tremeGENE™ HP (1:1), X-tremeGENE™ 9
(1:6), Nanofectin (1:3), Nanofectamin (1:6), ViaFect™ (1:6), TransIT-
X2® (1:2), JetPrime™ (1:2), and L3K (1:3) Results are mean ± SD
(n = 2). b Representative fluorescence micrographs 24 h post-
transfection with pMAX-GFP of adherent E14 mES cell cultures using
the five best-performing reagents from 1 A. c Flow cytometry quantifi-
cation of GFP-expressing E14 mES cells 24 h post-transfection in single
cell suspension using L2K (DNA/reagent ratio 1:4), TurboFect™ (1:4),
FuGENE® HD (1:4), TransIT-2020® (1:2), Xfect™ mESC (2:1), X-
tremeGENE™ HP (1:1), X-tremeGENE™ 9 (1:6), Nanofectin (1:3),
Nanofectamin (1:6), ViaFect™ (1:6), TransIT-X2® (1:2), JetPrime™
(1:2), and L3K (1:3) Results are mean ± SD (n = 2). d-e Trypan blue
dye exclusion assay for cell viability 24 h post-transfection of adherent
cultures (d) and single cell suspensions (e) using the five best-performing
reagents from 1 A and 1C. Results are mean ± SD (n = 2)
Fig. 3 Beta-galactosidase activity assay 24 h post-transfection with
pCMV β-galactosidase in E14 mES cells using L2K (DNA/reagent ratio
1:4), Nanofectamin (1:6), TransIT-2020® (1:2), ViaFect™ (1:6), Xfect™
mESC (2:1), X-tremeGENE™ HP (1:1), and TransIT-X2® (1:2). Results
are mean ± sd (n = 2)
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TransIT-X2 with 100 nM Oct3/4 siRNA. Oct3/4 expression
was markedly reduced 24 h post-transfection with 5, 15
and 30 min incubation (Fig. 4g). In fact, the level of
Oct3/4 expression was clearly lower than after similar
transfections in adherent 2i media cultures (Fig. 1a).
Hence, as expected, these novel transfection conditions seem
to work equally well for both plasmid-DNA as well as for
siRNA delivery.
Discussion
Over the years various biological, chemical, and physical
strategies for introducing nucleic acids into cells have been
developed. Today there are numerous commercially available
products optimized for certain cell or nucleic acid types.
Stem cells and primary cell cultures are often difficult
to transfect. Consequently, working with these cells of-
ten means accepting low transfection efficiencies or la-
borious optimizations. Instead many studies are carried
out in easily transfectable cell lines, such as HEK293 or
HeLa, despite being poor cell models. Multilayered
mES cell colonies give poor transfection efficiency due
to the lack of homogenous cellular access for transfec-
tion reagents and nucleic acid complexes. As we have
previously reported this quandary is even more trouble-
some when growing the cells in 2i media [2]. Moreover,
post-transfection intrusion on cellular proteostasis (e.g.
Fig. 4 a Flow cytometry quantification of GFP-expressing E14 mES
cells 24 h after short-time (5, 10, 15 and 30 min) transfection of single
cell suspensions using L2K (DNA/reagent ratio 1:2) and Nanofectamin
(1:6). Results are mean ± SD (n = 3) b Trypan blue dye exclusion assay
for cell viability 24 h 24 h after short-time (5, 10, 15 and 30 min) trans-
fection of single cell suspensions using L2K (DNA/reagent ratio 1:2) and
Nanofectamin (1:6). Results are mean ± SD (n = 3). c-d Beta-
galactosidase activity assay 24 h post-transfection with pCMV β-
galactosidase using L2K (1:2) and Nanofectamin (1:6) of adherent cul-
tures and single cell suspensions of E14 (c) and R1 (d) mES cells. e
Western blot analysis for β-actin and heparanase 24 h post-transfection
with pCAGGs-heparanase of adherent cultures or single cell suspensions
of E14 mES cells. f Flow cytometry quantification of GFP-expressing
E14 mES cells 24 h after short-time (5, 15 and 30 min) and standard-time
(2 and 4 h) transfection of adherent cultures (DNA/reagent ratios 1:2).
Results are mean ± SD (n = 3). g Quantitative PCR analysis for Oct3/4
24 h after short-time (5, 10, 15 and 30 min) transfection of single cell
suspensions with 100 nM siOct3/4 or scrambled siRNA using L2K and.
18S expression was used for normalization, and results are comparative
Ct value means ± SD (n = 2)
Stem Cell Rev and Rep (2016) 12:584–591 589
due to expression of plasmid DNA-encoded genes) and
subsequent decrease in proliferation rates result in cul-
tures being promptly overtaken by the less affected non-
transfected cells. Although the latter is a common con-
cern it becomes more critical for mES cells due to their
excessive proliferation rates and alternate day sub-
culturing needs.
In the present study we evaluated a panel of com-
monly used non-viral commercially available transfec-
tion reagents with regard to their applicability to deliver
plasmid DNA and siRNA into mES cells cultured in 2i
media. TransIT-X2 was found to be the most efficient
reagent for siRNA transfection of adherent mouse ES
cells cultured in 2i medium. When transfecting adherent
cultures with DNA plasmid, the Xfect mESC non-
liposomal polymer was the only reagent that generated
more than 50 % transfection rate. However, L2K
followed by Nanofectamin were the most efficient re-
agents when transfecting dissociated single cell suspen-
sions, suggesting that lipofection is the method of
choice for this experimental approach. Although Xfect
mES reagents at first glance seemed equally efficient as
L2K, the reagent was very toxic to cells in suspension.
Suspension transfection is not mentioned in the manufac-
turer’s instructions for the Xfect mESC reagent. However,
the traditional Xfect transfection reagent has been shown to
work for suspension cell cultures [10].
It is likely that the inefficient transfection of cells cultured
in 2i medium is partly due to the densely packed cell cultures
making the transfection agent less prone to access all the
cells. Enzymatic dissociation induces shaving of
membrane-associated factors, including glycoproteins
with highly sulfated glycosaminoglycan (GAGs) poly-
saccharide chains [11]. The large number of sulfate
groups renders the chains anionic, which allows interac-
tion with a wide variety of positively charged substrates.
Previous studies have shown that cell surface GAGs
interact with transfection reagent polymers and lipo-
somes and inhibit cation-mediated gene transfer [12].
Hence, the increase in transfection efficiency and trans-
gene expression observed after single cell suspension trans-
fections is likely a result of a combination of the homogenous
cellular accessibility for the transfection complexes in addition
to a temporary removal of GAGs from the plasma membrane
in response to trypsinization.
In an effort to fine-tune and reduce toxicity we optimized
the use of L2K for plasmid-DNA delivery in single mES cell
suspension. When optimizing transfection – whether for
stem cells or other cell types – various cell-related fac-
tors such as culture health, passage numbers, and culture
confluence need to be taken into consideration. However,
those variables will be highly research group- and cell lab-
dependent. Instead, we focused on parameters such as ratios
of nucleic acid to transfection reagent and incubation time.We
show that a DNA/reagent ratio of 1:2 rendered the best effi-
cacy without significantly increasing toxicity. Also, by reduc-
ing incubation times to just 5 to 10 min we could maintain a
high transfection efficacy but significantly increase cell via-
bility. In fact, completely omitting the suspension incubation,
and instead seeding the cells directly after adding the reagent
and DNA-complexes, yielded only a slight decrease in trans-
fection efficacy but a viability comparable to those obtained in
adherent culture transfections (data not shown). Furthermore,
similar results were obtained using R1 mES cells show-
ing that the high efficiency and low toxicity is indepen-
dent of cell line. Similar approaches have previously
been reported for other cell types [13–15]. Although
the focuses in those studies were on siRNA delivery,
the efficiency for plasmid-DNA delivery was also test-
ed. In concordance with our results these studies report-
ed that a 10–15 min incubation of trypsinized cells with
transfection complexes using L2K increases transfection
efficiency 2–9 fold and that incubation times longer
than that decrease cell viability. Consequently, this rapid
transfection approach, which is both more time-efficient
and gentle than the standard protocol, seems generally
applicable to numerous cell types. In conclusion, the
preferred method for plasmid DNA delivery of
mESCs, cultured in 2i medium, is by transfecting the
cells in suspension using L2K at a DNA:L2K ratio of
1:2 for 5–10 min. This gives a transfection rate of
>80 % with a survival of >75 %. Similarly, the most
efficient method for siRNA mediated knockdown is by
transfecting cells with TransIT-X2 or L2K for 5–
30 min, which mediates a > 90 % knockdown of
Oct3/4. In addition, transfecting trypsinized cells effec-
tively shortens the experimental time by one day as a
result of not having to plate the cells 24 h prior to
transfection as is required when transfecting adherent
cells.
In the past, cationic lipid and polymer-based transfec-
tion had yet to reach the levels observed with viral
transduction. With the presented method we have shown
that this is no longer the case and that high-efficient
transfections are achievable using non-viral methods.
The optimized methods presented herein offers solutions
to the current need for efficient and fast transfection in
order to simplify and enhance studies of individual
genes in pluripotent stem cells. Moreover, the method
of transfecting trypsinized cells would be very advanta-
geous in large scale and high-throughput transfection
applications.
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